열전도성 고분자와 Al재질의 Heat Sink 방열 성능 비교 분석

최두호,최원호,조주웅,박대희,Choi, Doo-Ho,Choi, Won-Ho,Jo, Ju-Ung,Park, Dae-Hee 한국전기전자재료학회 2015 전기전자재료학회논문지 Vol.28 No.2

The purpose of this study is examining thermal dissipation materials for the lighting and radiate efficiency improvement of 8W LED and confirming the properness of the thermal dissipation materials for LED heat sink. Solid Works flow simulation on 8W class COB was done based on the material characteristics of thermal conductive polymer materials. According to the result of simulation, Al had better thermal dissipation performance than PET. Highest temperature was $7.6^{\circ}C$ higher while lowest temperature was $7.8^{\circ}C$ lower. The test on the heat sinks made by the materials, highest temperature was $4.1^{\circ}C$ higher and lowest temperature was $3.9^{\circ}C$ lower. It is possible to confirm that Al heat sink has better thermal dissipation efficiency because it has better dispersion of heat generated at junction temperature and less heat cohesion. The weight of PET heat sink was reduced than Al heat sink by 46.9% by the density difference between Al and PET. In conclusion, thermal dissipation performance of thermal conductive polymer is lower than Al material however, it is possible to lighting heat sink because thermal conductive polymer has better formability, has lower specific weight and enables various design options.

한국의 젊은 여성유방암 환자에서 BRCA 배선유전자 돌연변이는 예후인자인가?

최두호,이민혁,Choi Doo Ho,Lee Min Hyuk,Haffty Bruce G. The Korean Society for Radiation Oncology 2003 대한방사선종양학회지 Vol.21 No.2

Purpose: The purpose of this study was to determine if there were prognostic differences between BRCA related and BRCA non-related Korean patients with early-onset breast carcinomas. Materials and Methods: Sixty women who had developed breast cancers before the age of 40, and who were treated at the Soonchunhyang University Hospital, were studied independently of their family histories. The age range was 18 to 40 with a median of 34.5 years. Lymphocyte specimens from peripheral blood were studied for the heterozygous mutations of BRCA1 and BRCA2 using direct sequencing methods. Immunohistochemistry was peformed on the paraffin-embedded tissue blocks that were available. Results: Eleven deleterious mutations (18.3%, 6 in BRCA1 and 5 in BRCA2) and 7 missense mutations of unknown significance (11.7%), were found among the 60 patients. More than half of the mutation were novel, and were not reported in the database. Most of the BRCA-associated patients had no history of breast cancer. No treatment related failures were observed in the BRCA carriers, with the exception of one patient that had experienced a new primary tumor of the contralateral breast. The seven year relapse free survival rate were 50 and 79% In the BRCA carrier and BRCA negative patients, respectively. Although the expression of estrogen and progesterone receptors were less common, and histological features more aggressive, in the BRCA associated tumors, the outcome of the patients with BRCA mutations was not poorer than that on the patients without deleterious mutations. Conclusion.: Despite the BRCA mutation carriers having adverse prognostic features, the recurrence rate was relatively lower than that in the BRCA non-carrying Korean patients wi4h early-onset breast carcinomas. In addition, although the prevalence of the BRCA mutation in Korean patients was higher than that in white patients, the penetrance of the cancer seemed to be relatively low in Korean women carrying BRCA mutations. A large population based study of the BRCA mutation, with a long-term follow-up of the study patients will be required to confirm these results.

도시조직과의 연계성 확보를 위한 공동주택 계획기법에 관한 연구 - 강일2지구 공동주택 현상안 분석을 중심으로 -

최두호,이주형,Choi, Doo-Ho,Lee, Joo-Hyung 한국주거학회 2006 한국주거학회 논문집 Vol.17 No.6

In the planning process, there are five directions to planning residential sites. Firstly, the site must be planned to allow continuity with the city space, or created to conform to the city structure. Secondly, plans for community space and programs as well as convenience facilities must coexist in the road space. Thirdly, in terms of view, the site must be planned in territories to secure identity of the site. Fourthly, in terms of the environment, the site should utilize the natural environment. Lastly, in terms of infrastructure, the site should include a pedestrian-centered road system as well as establishing city infrastructure facilities for a combined planning in the municipal dimension. So far we have looked at planning methods for an apartment site that can be integrated into the existing city. The study into five elements to planning a large-scale apartment site, context, community, landscape, environment and infrastructure, and their relationship among each other must continue on.

식용버섯과 진균 교차 배양을 활용한 플라스틱 필름의 생물학적 분해효과

최두호,이은지,안기홍,이강효,Doo-Ho Choi,Eunji Lee,Gi-Hong An,Kang-Hyo Lee 한국버섯학회 2024 한국버섯학회지 Vol.22 No.1

Plastics are widely used in industries in human society and because of their structural stability, degradation is a serious global issue. To estimate the degradation of plastic, 31 edible mushrooms were cultured with the selected plastic films (polyethylene [PE], polystyrene [PS], and poly(ethylene terephthalate) [PET]) for 3 months at 25 ℃. Measuring the weight of the films showed that four species of mushrooms, namely Porostereum spadiceum, Ganoderma lucidum, Coprinellus micaceus, and Pleurotus ostreatus, exhibited the highest degrees of plastic degradation. In addition, the mushrooms and fungi that exhibited the most significant plastic degradation were cross-cultured to promote this degradation. As a result, cross-cultivation of G. lucidum and Aspergillus niger showed a weight loss of 2.49% for the PET film. For the PS film, Aspergillus nidulans showed a weight loss of 4.06%. Cross-cultivation of A. nidulans and C. micaceus, which showed a weight loss of 2.95%, was noted as an alternative for PS biodegradation, but is harmful to humans. These bio-degradation effects of edible mushroom will contribute to the development of alternatives for eco-friendly plastic degradation.

국내 봉화 송이 자생지 내 균환 유래 토양세균의 송이균사체 생장촉진 효과

최두호,이은지,이강효,안기홍,Doo-Ho Choi,Eunji Lee,Kang-Hyo Lee,Gi-Hong An 한국버섯학회 2024 한국버섯학회지 Vol.22 No.1

As a member of ectomycorrhizal fungi, Tricholoma matsutake has a symbiotic relationship with its host, Pinus densiflora. To cultivate T. matsutake artificially, the co-cultivation of T. matsutake mycelia and bacteria from shiro was introduced. In this study, bacteria were isolated from soil samples in Bonghwa-gun, and seven bacterial isolates (B22_7_B05, B22_7_B06, B22_7_B07, B22_7_B08, B22_7_B10, B22_7_B13, and B22_7_B14) promoted the growth of T. matsutake mycelia (147.48, 232.11, 266.72, 211.43, 175.17, 154.62, and 177.92%, respectively). Sequencing of the 16S rRNA region of the isolated bacteria was performed. B22_7_B05 and B22_7_B10 were identified as Bacillus toyonensis, B22_7_B06 and B22_7_B08 as Paenibacillus taichungensis, B22_7_B07 and B22_7_B14 as P. gorilla, and B22_7_B13 as P. odorifer. These bacterial isolates were associated with the shiro community and are expected to contribute to the cultivation of T. matsutake.

국내 양양 송이 자생지 내 균환 유래 토양미생물과 송이균사체 생장촉진 효과

최두호,이은지,이강효,안기홍,Doo-Ho Choi,Eunji Lee,Kang-Hyo Lee,Gi-Hong An 한국버섯학회 2024 한국버섯학회지 Vol.22 No.1

Tricholoma matsutake is a traditional favorite food in East Asia, cultivated in fairy rings called "shiro," which are found near Pinus densiflora. For effective artificial cultivation of Tri. matsutake, microorganisms from symbiotic fairy rings are co-cultivated. In this study, one bacterial isolate (Y22_B35) and two fungal isolates (Y22_F64 and Y22_F68) displayed growth-promoting effects on Tri. matsutake mycelium (158.47, 125.00, and 122.26% enhanced growth, respectively). For identification, 16S rRNA or ITS regions from the microorganisms¡¯ genomes were sequenced. Other sequences, including BenA, CaM, and RPB2 were sequenced in the fungal isolates. The bacterial isolate Y22_B35 was identified as Bacillus cereus. Y22_F64 and Y22_F68 were identified as Umbelopsis nana and Aspergillus parvulus, respectively. To identify the effects of the dominant microorganisms on Tri. Matsutake cultivation, metagenomic analyses were performed. Discovery of these Tri. matsutake mycelium growth-promoting microorganisms and metagenomics analyses are expected to contribute to our understanding of Tri. matsutake fruiting body growth and construction of biomimicry.

한국인과 백인 젊은 여성 유방암 환자에서 Cyclooxygenase-2 발현과 HER-2/neu 증폭의 비교 연구

최두호(Doo Ho Choi),김은석(Eun Seog Kim),김용호(Yong Ho Kim),진소영(So Young Jin),이동화(Dong Wha Lee),Bruce G. Haffty 대한방사선종양학회 2004 대한방사선종양학회지 Vol.22 No.4

목적: 한국인은 젊은 여성 유방암의 비율이 높으며 저자들의 선행 연구에서 HER-2/neu 과발현이 백인에 비해 높 았으며 나쁜 예후 인자였다. 이 환자들을 대상으로 COX-2 발현의 비교와 HER-2/neu 과발현의 관계를 비교하고 한국인에서 COX-2의 예후인자로서의 역할을 알아보기 위해 이 연구를 시행하였다. 대상 및 방법: 45세 이하의 한국인 여성 유방암 환자와 같은 나이의 백인 여성 환자 60명의 파라핀 포매조직을 이용하여 COX-2 염색을 시행하였다. COX-2 발현을 판독하고 한국인과 백인의 발현 비율을 비교하였다. 그리고 한국인 환자의 추적 검사 결과와 COX-2 관계를 조사하여 예후인자로서의 역할을 연구하였다.결과: 판독이 가능한 전체 환자의 COX-2 발현 비율은 27.6% 이었으며 한국인은 37.9%, 백인은 20.8%로 한국인 젊은 여성의 비율이 다소 높았으나 통계적인 유의성은 없었다(p=0.090). 전체 환자의 COX-2 발현과 HER-2/neu 과발현의 상관 관계는 발견하지 못하였지만 에스트로겐 수용체 음성과 COX-2 발현은 통계적으로 유의한 관계가 있었다.(p=0.046) COX-2 양성의 5년 무병 생존율은 67.9%로 COX-2 음성의 81.6%에 비해 낮았으나 통계적인 유의성이없었다(p=0.3607).결론: 젊은 여성 유방암 환자에서 한국인과 백인간의COX-2 발현 비율의 차이는 통계적으로 유의하지 않았으며 HER-2/neu 과발현과의 관련성도 없었으며 예후와의 관련성도 통계적으로 유의하지 않았고 에스트로겐 수용체 음성과의 관련성은 있었다. COX-2 발현과 다른 임상적 병리적 인자와의 관계나 예후인자로서의 역할을 찾기 위해보다 많은 환자를 대상으로 한 연구가 필요하며 COX-2 발현에 따라 방사선치료가 예후에 미치는 영향에 관한 연 구도 필요하다. Purpose: The purpose of this work was to study the differences of cyclooxygenase (COX-2) expression between Korean and Caucasian patients with early-onset breast carcinoma by immunohistochemistry. The test were analyzed to find a correlation between COX-2 and other biomarkers including HER-2/neu amplification, because we previously reported that a significant difference had been found in the expression of HER-2/neu between the two races. Furthermore, we investigated prognostic significance of COX-2 in Korean patients. Materials and Methods: Sixty Korean women who were diagnosed breast carcinoma at 45 years old or younger and 60 Caucasian women with breast carcinoma were selected for this study. The median age of both groups was 37 years and tumor sizes were distributed evenly between the two group. Paraffin embedded blocks of primary tumor were processed for immunohistochemical staining of COX-2. The COX-2 expression was evaluated according to the percentage of positive cells and the intensity of staining. And the results were compared with the data of the previous studies to find correlation between COX-2 and other parameters and survival data. Results: Proportion of the COX-2 expression in total patients was 27.6%. The percentage of tumors that stained positive for COX-2 in Korean and Caucasian women with early-onset breast carcinoma were 37.9% and 20.8%, respectively. The difference was statistically not significant(p=0.090). Expression of COX-2 was not associated with several clinicopathologic parameters including HER-2/neu overexpression, but negative estrogen receptor status was correlated with significance (p=0.046). The 5 year disease free survival rate for patients with COX-2 expression was 67.9%, compared to 81.9% of the COX-2 negative patients and the result was statistically not significant. Conclusions: A significant difference was not found in the expression of COX-2 between the two groups of patients with early-onset breast carcinoma. And correlation between COX-2 and other parameters was not observed except estrogen receptor negativity. Large scaled further research including radiotherapy factors will be needed to identify COX-2 as a prognostic role in patients with early-onset breast carcinoma.

젊은 한국인 유방암 환자에서 BRCA1/2 돌연변이와 호르몬 수용체, HER-2 상태에 관한 연구

최두호(Doo Ho Choi),진소영(So Young Jin),이동화(Dong Wha Lee),김은석(Eun Seog Kim),김용호(Yong Ho Kim) 대한방사선종양학회 2008 대한방사선종양학회지 Vol.26 No.1

목 적: 40세 이하의 젊은 여성 유방암 환자는 나이 든 여성 보다 BRCA1과 BRCA2 배선돌연변이의 빈도가 상대적으로 높다. 유방암 가족력이 있거나 젊은 나이에 유방암을 진단받은 백인 여성들의 BRCA1/2 돌연변이 암에 대한연구에서 면역조직화학적으로 BRCA1/2 돌연변이 음성인 암과 다른 특성이 발견되었다. 이 연구의 목적은 유방암가족력과 관계없이 젊은 나이에 유방암이 발생한 한국 여성을 대상으로 BRCA1/2 돌연변이 유뮤에 따라, 그리고BRCA1과 BRCA2 각각의 돌연변이에 따라 면역조직화학적 특성으로 상호간의 구별이 가능한지, 면역조직화학적검사로 BRCA1/2 돌연변이의 가능성을 알아보는 것이 가능한지를 조사하는데 있으며 BRCA와 관련된 암의 예후인자로서의 역할도 분석하였다. 대상 및 방법: BRCA1/2 검사를 시행한 40세 이하의 한국인 젊은 여성 유방암 환자의 유방암 수술 후 병리조직을 찾아서 조직미세배열법으로 슬라이드를 만들었다. 이 검체들의 병리조직, 등급, 림프절 전이, T 병기, 에스트로겐 수용체, 프로게스테론 수용체 및 HER-2 상태와 BRCA1/2의 관계를 비교하였다. 그리고 이 환자들의 BRCA 돌연변이 상태와 면역조직학적, 병리학적 상태와 예후 인자로서의 역할도 조사하였다. 결 과: BRCA1/2 돌연변이를 조사한 101명 중 14명에서 16개의 돌연변이가 있었으며(13.9%), 유방암-난소암 가족력이 있는 경우(4/14, 28.6%), 양측성 유방암이 있는 경우(3/9, 33.3%)에 BRCA1/2 돌연변이 빈도가 높았다. 에스트로겐 수용체 음성인 경우 BRCA1/2 양성이 19.4% (12/62)로 에스트로겐 수용체 양성 비율 5.1% (2/37)에 비해 유의하게 높았고(p=0.038), HER-2 음성인 경우 BRCA1/2 돌연변이 음성 비율이 16.5% (13/79)로 양성 비율 4.5% (1/22)에 비해 높은 경향을 보였으며(p=0.073), 프로게스테론 수용체는 차이가 없었다. 에스트로겐 수용체, 프로게스테론 수용체 및 HER-2 모두 음성인 경우(triple negative)는 BRCA1/2 돌연변이 비율이 24.2% (8/33)로 매우 높았 다. 종양의 크기, 림프절 전이 상태, HER-2 상태는 단변량 변수와 다변량 변수 모두에서 무병 생존에 유의한 영향 을 미치는 인자 이었으나 BRCA1/2 돌연변이 상태는 무병생존에 유의한 인자가 아니었다. 결 론: 면역조직화학적으로 에스트로겐 수용체나 HER-2 음성을 보이는 젊은 유방암 환자에서 BRCA1/2 돌연변이 발생이 유의하게 높았으며, 프로게스테론 수용체까지 모두 음성인 경우 BRCA1/2 돌연변이가 있을 확률이 24.2%로 높아서 유방암 유전자 돌연변이 가능성을 예측하는데 도움을 줄 수 있다. 한국인 젊은 여성 유방암 환자에서 BRCA1/2 돌연변이 상태가 무병생존에 유의한 인자는 아니었으나 좀 더 많은 환자와 긴 추적관찰 기간의 추가적인 연구가 필요하다. Purpose: Women with breast cancer diagnosed at an age of 40 years or younger have a greater prevalence of germline BRCA1 and BRCA2 mutations than the prevalence of women with breast cancer diagnosed at older ages. Several immunohistochemical characteristics have been identified in breast cancers from studies of Caucasian women with BRCA1/2 mutations having familial or early-onset breast cancers. The aim of this study is to determine whether early-onset breast cancer in BRCA1 or BRCA2 mutation carriers, who were not selected from a family history, could be distinguished by the use of immunohistochemical methods and could be istinguished from breast cancer in women of a similar age without a germline BRCA1 or BRCA2 mutation. We also analyzed the prognostic difference between BRCA1/2 related and BRCA1/2 non-related patients by the use of univariate and multivariate analysis. Materials and Methods: Breast cancer tissue specimens from Korean women with early-onset breast cancers were studied using a tumor tissue microarray. Immunohistochemical staining of estrogen receptor (ER), progesterone receptor (PR) and HER-2, as well as the histology and grade of these specimens, were compared. The prognostic impact of immunohistochemical and histological factors as well as the BRCA1/2 mutation status was investigated separately. Results: There were 14 cases and 16 deleterious BRCA1/2 mutations among 101 patients tested. A family history (4/14) and bilateral breast cancers (3/9) were high risk factors for BRCA1/2 mutations. BRCA1/2- associated cancers demonstrated more expression of ER-negative (19.4% versus 5.1%, p=0.038) and HER-2 negative than BRCA1/2 negative tumors, especially for tumors with BRCA1 tumors The BRCA1/2 mutation rate for patients with triple negative tumors (negative expression of ER, PR and HER-2) was 24.2%. Tumor size, nodal status, and HER-2 expression status were significantly associated with disease free survival, as etermined by univariate and multivariate analysis, but the BRCA1/2 status was not a prognostic factor. Conclusion: Breast cancer that occurs in women with a germline BRCA1 or BRCA2 mutations have recognizable immunohistochemical features, which may be useful in identifying individuals that are more likely to carry germline mutations. Although the BRCA1/2 mutation status was not a prognostic factor in Korean women with early-onset breast cancer, more cases with a longer follow-up period are needed for further study.

자궁경부암 치료 후 재발양상과 종양표지자 SCC항원의 혈청 수치 변화의 상관관계에 관한 연구

최두호(Doo Ho Choi),김은석(Eun Seog Kim),남계현(Kae Hyun Nam) 대한방사선종양학회 1999 대한방사선종양학회지 Vol.17 No.2

목 적 : 방사선치료를 시행한 자궁경부암 환자에서 혈중 SCC항원을 치료 전과 치료 후 추적기간 동안의 수치변화와 치료 결과의 상관관계를 조사하기 위하여 자료를 분석하였다. 대상 및 방법 : 순천향대학병원 방사선종양학과에서 방사선치료를 시행한 환자 중에서 1991∼1997년 사이에 혈중 SCC 검사를 치료 전 시행하였거나 추적관찰 중 시행한 181명의 환자를 대상으로 후향적 분석을 실시하였다. 여러 가지 통계 방법을 통하여 치료 전 농도와 무병생존기간, 예후인자 등을 비교하고 추적기간 중 수치 변화의 임상적의미를 조사하였 다. 결 과 : 혈중 SCC항원의 양성비율은 1.5ng/ml 기준으로 병기그룹에 따라 71∼91%, 2.5ng/ml 기준으로 57∼91%로 유의하 게 증가하였으며 각 그룹의 5년 무병생존율은 I B-ⅡA 79.2%, ⅡB 68.7%, Ⅲ 33.4%, Ⅳ 0% 였다. 그리고 5년 무병생존율 은 치료 전 항원농도가 5ng/ml 이상인 경우 34%로 1.5ng/ml 이하, 1.5∼5ng/ml의 55∼62% 보다 매우 낮았다. 항원 수치 추적검사 결과 임상증상보다 1∼13개월(평균 4.8개월) 재발을 빨리 발견할 수가 있었고 항원의 수치와 무병생존기간은 유의한 상관관계를 가졌고(r=-0.266) 다변량 분석상 치료전 SCC항원의 수치는 독립된 예후인자였다. 결 론 : 치료 전 혈중 SCC항원 농도는 편평상피 자궁경부암의 예후에 영향을 미치는 인자이며 치료 후 추적기간 중에 하 는 검사는 재발을 빨리 발견하는데 유용하다. Purpose : Serum squamous cell (SCC) antigen levels were examined in uterine cervix cancer undergoing radiation therapy, and authors analyzed the relationship between SCC antigen levels and treatment results. Materials and Methods : This is a retrospective st udy of 181 cervical carcinoma patients who received radiotherapy and examined serial serum SCC antigen from 1991 to 1997 at Soonchunhyang University Hospital. One hundred and eighteen patients underwent SCC antigen evaluation at diagnosis The relationship between the serum tumor marker level and disease free survival, recurrence pattern, and other prognostic factors were analyzed according to various statistical methods. Results : The positivity rate (initial serum value above 2.5 ng/ml) was increased with FIGO stage (IB-Ⅱ A 57% to IV 91%) and more discriminative than cutoff value of 1.5 ng/ml. Five year disease free survival rates for the stage IB-IIA, IIB, III and Ⅳ were 79.2%, 68.7%, 33.4% and 0%, respectively. The 5-year disease free survival rate for patients with serum SCC antigen levels above 5.0 ng/ml was 34% versus 55 ∼ 62% for patients with normal range (<1.5 ng/ml) or mildly elevated levels (1.5∼ 5.0 ng/ml). Rising SCC antigen levels preceded the clinical detection of disease by a mean of 4.8 months (range 1∼13 months). Negative linear corelation was observed between initial SCC antigen levels and relapse free survival (r= -0.226), and by multivariate analysis, initial SCC antigen level had a large impact on the relapse free survival. Conclusions : SCC antigen assay is a useful aid to predict the prognosis of squamous cell carcinoma of the uterine cervix and to detect recurrence.

한국에서 자궁경부암 방사선치료의 Patterns of Care Study 진행을 위한 문헌 비교 연구

최두호(Doo Ho Choi),김은석(Eun Seog Kim),김용호(Yong Ho Kim),김진희(Jin Hee Kim),양대식(Dae Sik Yang),강승희(Seung Hee Kang),우홍균(Hong Gyun Wu),김일한(Il Han Kim) 대한방사선종양학회 2005 대한방사선종양학회지 Vol.23 No.2

목 적: 한국인의 여성암 중에서 호발하는 암 중의 하나인 자궁경부암의 검사 및 치료 형태와 치료 결과가 발표된 연구 논문을 통해 분석하고 미국과 일본 자궁경부암의 Patterns of Care Study (PCS)와 비교하여 한국실정에 맞는 PCS 문항 개발의 진행을 위한 기본 자료를 제시하기 위해 문헌 비교 연구를 시행하였다.대상 및 방법: 외국의 PCS 관련 자료는 PCS 홈페이지에 소개된 212편의 논문 및 초록 중에서 자궁경부암및 PCS 구조부분의 논문(42편)과 최근에 발표된 논문을 대상으로 하였으며 한국에서 연구된 것은 Korean Pub Med에서 자궁경부암과 방사선치료에 관한 자료를 구하고(99편) 외국 잡지에 발표된 것을 포함하여 PCS의 비교 대상을 선정하여 PCS의 구조(Structure), 진행(Process), 결과(Outcome) 의 순서에 따라 비교 분석하였으며 시대에 따른 PCS의 패턴을 분석하기 위해 1980년대 이전과 1990년대 이후의 연구 결과로 나누어서 분석하였다. 결 과: 미국과 일본에서 자궁경부암의 PCS에 관한 논문이 각각 28편과 10편이 분석 가능하였고 한국은 73편이 PCS에서 다루는 항목을 포함하여 분석 가능하였다. 미국과 일본의 PCS는 공통적으로 치료기관의 규모, 의사 및 환자 수, 그리고 치료기관의 성격에 따라 계층화된 3∼4개의 구조로 나누고 연구 대상 환자를 엄격하게 제한하였다. 그리고 연구의 진행을 위해 치료 전 병기 결정과정의 요소들을 나누고 시대에 따른 병기결정의 요소들을 분석하였으며 치료와 관련된 여러 가지 인자들을 다루고 FIGO 병기 이외의 예후인자들도 자세히 분석하며 기계에 대한 비교분석이 잘 되어 있다. 그러나 미국과 일본의 PCS도 그 나라의 특성상 미국은 인종간의 특성, 사회경제적 계층에 대한 분류를 시도하고 있으며, FIGO 병기에서 다루지 않은 종양의 크기(6편), 자궁방 또는 골반벽 침범이 한쪽 또는 양쪽으로 진행된 것에 따른 치료 결과의 분석이 활발하였고(5편), 일본은 종양표지자에 대한 연구가 포함되어 있다. 그리고 병기 결정 과정에서 공통적인 시대적 변화는 창기의 림프과조영술, 바륨 관장술이 점차 사라지고 나중에 CT, MRI의 비중이 높아졌다. 한국 자료는 주로 일 기관에서 한 연구로 구조(Structure)에 대한 언급이 없으며 기계적 특성에 따른 차이도 거의 분석하지 않았다. 그러나 최근의 연구 주제는 미국, 일본의 PCS에서 잘 다루지 않던 항암제의 병용 요법(9편), 치료기간(4편) 종양표지자(8편), 비전형적 분획 등을 다루고 있다. 론: 여러 나라의 문헌을 비교 분석하여 한국에서 필요한 자궁경부암의 PCS를 이용한 문항개발이 이루어졌다. 그리고 후속적인 연구로 진행될 근접치료기 사용 및 치료의 결과, 부작용 등의 비교 분석을 포함하여 한국형 자궁경부암 PCS에서 필요한 항목을 합의 도출하여 완성하였으며 이 내용을 토대로 향후 표준화된 치료 모델 개발을 위한 PCS가 진행될 수 있으며 환자의 치료에 있어서 부족했던 분야에 대해 교정할 수 있는 교육적인 목적도 제시할 수 있을 것이다. Purpose: Uterine cervix cancer is one of the most prevalent women cancer in Korea. We analysed published papers in Korea with comparing Patterns of Care Study (PCS) articles of United States and Japan for the purpose of developing and processing Korean PCS. Materials and Methods: We searched PCS related foreign-produced papers in the PCS homepage (212 articles and abstracts) and from the Pub Med to find Structure and Process of the PCS. To compare their study with Korean papers, we used the internet site “Korean Pub Med” to search 99 articles regarding uterine cervix cancer and radiation therapy. We analysed Korean paper by comparing them with selected PCS papers regarding Structure, Process and Outcome and compared their items between the period of before 1980's and 1990's. Results: Evaluable papers were 28 from United States, 10 from the Japan and 73 from the Korea which treated cervix PCS items. PCS papers for United States and Japan commonly stratified into 3∼4 categories on the bases of the scales characteristics of the facilities, numbers of the patients, doctors. Researchers restricted eligible patients strictly. For the process of the study, they analysed factors regarding pretreatment staging in chronological order, treatment related factors, factors in addition to FIGO staging and treatment machine. Papers in United States dealt with racial characteristics, socioeconomic characteristics of the patients, tumor size (6), and bilaterality of parametrial or pelvic side wall invasion (5), whereas papers from Japan treated of the tumor markers. The common trend in the process of staging work-up was decreased use of lymphangiogram, barium enema and increased use of CT and MRI over the times. The recent subject from the Korean papers dealt with concurrent chemoradiotherapy (9 papers), treatment duration (4), tumor markers (8) and unconventional fractionation. Conclusion: By comparing papers among 3 nations, we collected items for Korean uterine cervix cancer PCS. By consensus meeting and close communication, survey items for cervix cancer PCS were developed to measure structure, process and outcome of the radiation treatment of the cervix cancer. Subsequent future research will focus on the use of brachytherapy and its impact on outcome including complications. These finding and future PCS studies will direct the development of educational programs aimed at correcting identified deficits in care.